News for Definitive Healthcare Corp. (DH)

PR NewswireDUBLIN, Ohio, March 10, 2025 DUBLIN, Ohio, March 10, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors

On March 3, 2025, Advent International, L.P. (Trades, Portfolio) executed a substantial reduction in its holdings of CCC Intelligent Solutions Holdings Inc (CCC

FRAMINGHAM, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare ( DH), an industry leader in healthcare commercial intelligence, today announced t

Definitive Healthcare Corp. (NASDAQ:DH) Q4 2024 Results Conference Call February 27, 2025 5:00 PM ETCompany ParticipantsMatthew Ruderman - Investor...

Texas-based Interactive Strength Inc. (TRNR) is up over 30 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

Total Revenue: $62.3 million, down 6% year-over-year.Adjusted EBITDA: $17.5 million, down 12% year-over-year.Adjusted EBITDA Margin: 28%.Unlevered Free Cash Fl

Feb 27, 2025 / 10:00PM GMTOperator Welcome to Definitive Healthcare's Q4 2024 earnings call. (Operator Instructions) I would like to now turn the call over to y

Definitive Healthcare (DH) delivered earnings and revenue surprises of 14.29% and 3.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Quarterly Revenue: $62.3 million, surpassing the estimated $60.59 million despite a 6% decrease from Q4 2023.Quarterly Net Loss: $(84.7) million, significantly

Fourth quarter and full year 2024 revenue exceeded guidance FRAMINGHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (”œDefinitive

FRAMINGHAM, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (”œDefinitive Healthcare”) ( DH), an industry leader in healthcare commerc

**media[540315]**

Definitive Healthcare, a SaaS-enabled technology solution company, is focused on the healthcare industry. Click here to find out why I rate DH stock a hold.

Definitive Healthcare (DH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

**media[527452]**

Definitive Healthcare (DH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

**media[510096]**

Definitive Healthcare's chief product & tech officer sells $211,500 in stock

Definitive Healthcare (DH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.